Sign inJoin waitlistJoin the waitlist

Dana Salzberg

Interim Co-Director, Blood and Marrow Transplant Program · University of Arizona College of Medicine - Phoenix

Credentials: · · · ·

History

Blood and Marrow Transplant Program · University of Arizona College of Medicine - Phoenix
Present

Hematology and Medical Oncology
University of Colorado School of Medicine
2006–2009
Pediatric Hematology Oncology
University of Colorado School of Medicine
2003–2006
Ann & Robert H Lurie Children's Hospital of Chicago
1999–2002
Morehouse School of Medicine
1995–1999

Research

Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma
Blood Advances · 2020 · 376 citations
Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity
Molecular Cancer Therapeutics · 2010 · 126 citations
Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia
Clinical Cancer Research · 2006 · 100 citations

Alexander Ngwube
14 papers
Holly Miller
13 papers
Kristen Beebe
13 papers
RA
Roberta Adams
13 papers
Charlotte Schwalbach
6 papers
Jennifer Stahlecker
5 papers
Amy Keating
4 papers
Biljana Horn
3 papers
Douglas Graham
3 papers
JB
Jessica Bodea
3 papers · 3 as a fellow
Xiayuan Liang
3 papers
Christine Phillips
2 papers

Clinical trials

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2030
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Site PI · Recruiting · Phase 1, Phase 2
Tanja Andrea Gruber
2023–2033
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Site PI · Recruiting · Phase 1, Phase 2
PedAL BCU, LLC
2022–2030
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2020–2028